Oral Co-Supplementation of Curcumin, Quercetin, and Vitamin D3 as an Adjuvant Therapy for Mild to Moderate Symptoms of COVID-19—Results From a Pilot Open-Label, Randomized Controlled Trial

Overview of attention for article published in Frontiers in Pharmacology, June 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news: 12 news outlets
twitter: 199 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 33 Dimensions

Readers on

mendeley: 55 Mendeley

Summary News X Facebook Dimensions citations

So far, Altmetric has seen 1 public wall post.

Evolutamente.it, 23 Aug 2022

CURCUMINA E…

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity.